Sign in

CIK 0001604464

  • Non-accelerated filer
  • Smaller reporting company

Atara Biotherapeutics, Inc.

Sign in to watch
Ticker
ATRA
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
460920988
Phone
+1 805-623-4211
Business address
1280 RANCHO CONEJO BLVD, THOUSAND OAKS, CA, 91320
  1. 4 Open-market sale Chief Financial Officer sold 6,255 shares at an average $4.49 ($28,086)
  2. 4 Open-market sale President and CEO sold 14,806 shares at $5.04 ($74,548)
  3. 4 Open-market sale EVP, Head of R&D sold 4,124 shares at $5.03 ($20,760)
  4. 4 Open-market sale SVP, GC & Secretary sold 3,430 shares at an average $5.03 ($17,269)
  5. 4 Open-market sale Chief Financial Officer sold 5,940 shares at $5.04 ($29,908)
  6. 4 Open-market sale President and CEO sold 14,220 shares at $7.20 ($102,384)
  7. 4 Grant or award Director acquired 20,500 shares (grant or award)
  8. 4 Grant or award Director acquired 20,500 shares (grant or award)
  9. 4 Grant or award Director acquired 20,500 shares (grant or award)
  10. 4 Grant or award Director acquired 20,500 shares (grant or award)
  11. 4 Grant or award Director acquired 20,500 shares (grant or award)
  12. 4 Grant or award Director acquired 20,500 shares (grant or award)
  13. 4 Grant or award Director acquired 20,500 shares (grant or award)
  14. 4 Grant or award Director acquired 20,500 shares (grant or award)
  15. 4 Grant or award Director acquired 20,500 shares (grant or award)
  16. 4 Open-market sale Chief Financial Officer sold 5,853 shares at $5.63 ($32,952)
  17. 4 Open-market sale SVP, GC & Secretary sold 3,223 shares at an average $5.32 ($17,134)
  18. 4 Open-market sale Chief Financial Officer sold 5,582 shares at an average $5.32 ($29,675)
  19. 4 Open-market sale EVP, Head of R&D sold 3,873 shares at $5.32 ($20,597)
  20. 4 Open-market sale President and CEO sold 13,913 shares at $5.32 ($73,962)

Page 7 of 33 · 644 filings